Atherosclerotic Cardiovascular Disease Risk Assessment

Atherosclerotic Cardiovascular Disease Risk Assess

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK ASSESSMENT

Implementation of Risk Assessment
Work Group Recommendations


Does the patient have existing clinical ASCVD?		Yes	▶	See AHA/ACC Secondary Prevention Guideline
Does the patient have existing clinical ASCVD?			▶	See AHA/ACC Secondary Prevention Guideline
	No
▼
Is the patient <20 years or >79 years of age?		Yes	▶	See Pediatric Guidelines and ACC/AHA Adult Primary Prevention Guidelines • Blood Cholesterol • Obesity
Is the patient <20 years or >79 years of age?			▶
	No
▼
Assess traditional risk factors every 4–6 years in patients 20–79 years of age; estimate 10-year risk in those 40–79 years of age using Pooled Cohort Equations			Elevated 10-year risk (≥7.5%)		▶	Communicate risk data and refer to AHA/ACC Prevention Guidelines • Blood Cholesterol • Obesity
					▶
	Low 10-year risk (<7.5%)
▼
Assess 30 year or lifetime risk in those 20–59 years of age; Communicate risk data regardless of age and refer to AHA/ACC Lifestyle Guideline

American College of Cardiology (ACC) and the American Heart Association (AHA) have released a new clinical practice guideline to assist primary care clinicians in identifying adults who may be at high risk for developing atherosclerotic cardiovascular disease (ASCVD) and who may benefit from lifestyle changes or drug therapy for prevention. The figure above is a suggested approach for incorporating ASCVD risk assessment recommendations made by the Work Group into clinical practice.

REFERENCES

Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013.
Available at: http://circ.ahajournals.org/content/early/
2013/11/11/01.cir.0000437741.48606.98.full.pdf+html.

(Rev. 6/2018)

Want to read more?